ArticlePLoS computational biology2026
Structure-aware deep learning enhances m6A prediction and reveals cell type-associated RNA structural signatures.
Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
N6-methyladenosine (m6A), the most abundant mRNA modification in eukaryotes, plays essential roles in gene regulation and disease pathogenesis. Computational prediction of m6A sites offers a scalable alternative to costly experimental approaches, yet current methods rely predominantly on linear sequence features. This overlooks potentially informative RNA structural context, which is associated with local methylation patterns and may provide complementary predictive information beyond linear sequence motifs. To incorporate this complementary information, we propose SMART-m6A (Sequence-structure Multifeature Attention RNA Transformer for m6A), a deep learning framework that integrates sequence and structural information through parallel convolutional feature extraction and structure-guided attention for multifeature fusion. SMART-m6A achieves superior predictive performance compared to existing methods, with particularly clear advantages in sequence-ambiguous candidates. Beyond prediction accuracy, learned attention patterns reveal strong concordance with experimentally validated m6A-binding protein recognition sites and identify potentially novel regulatory motifs. Through systematic ablation studies and targeted structural-input perturbation analyses, we show that sequence and structure provide complementary predictive information, and that sites with greater prediction sensitivity to structural perturbation exhibit distinct local structural profiles between cell lines. Collectively, this work demonstrates the predictive value of sequence-derived structural features in m6A modeling and provides a multifeature deep learning framework for accurate and interpretable structure-aware epitranscriptomic prediction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.